PharmaVOICE Blog Post

Moving the Needle Forward on Multiple Sclerosis Research (Webinar)

Posted By: Dan Limbach
June 29, 2018

Are we closer to finding a cure for MS? Attend this webinar to find out.
July 11, 2018 | 10:00am ET

Discover insights from the experts at GeNeuro, a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases, about the first clinical efficacy study of GNbAC1, a promising new approach for the treatment of MS.

Worldwide Clinical Trials partnered with GeNeuro, and the results of the study are astounding.

During this webinar, attendees will:

  • Get insights into a real case study showcasing results from a recent Phase IIb Relapsing-Remitting Multiple Sclerosis (RRMS) clinical trial
  • Understand the trial strategy and how key endpoints related to neuroprotection were selected
  • Identify risk mitigation strategies that can be leveraged across CNS indications to reduce clinical development time and costs
  • Learn about the breakthrough results of this study and what they mean for future MS research
  • Hear what investigators are saying about the regulatory and commercial outlook of the final product

Register now to learn about a promising new approach for the treatment of MS

About the Blog Poster: Dan Limbach

Post a Comment

You must be logged in to post a Comment.